These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22670048)

  • 21. Knowledge, attitudes, and practices of US practitioners who provide pre-travel advice.
    Kogelman L; Barnett ED; Chen LH; Quinn E; Yanni E; Wilson ME; Benoit C; Karchmer AW; Ooi WW; Jentes ES; Hamer DH
    J Travel Med; 2014; 21(2):104-14. PubMed ID: 24593023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy and safety of vaccination against yellow fever of persons traveling to endemic areas].
    Dabrowska MM; Flisiak R
    Przegl Epidemiol; 2010; 64(2):319-22. PubMed ID: 20731245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The US-Certified Yellow Fever Vaccination Center Registry: a tool for travelers, state health departments, and vaccine providers.
    Russell MN; Cetron MS; Eidex RB
    J Travel Med; 2006; 13(1):48-9. PubMed ID: 16412108
    [No Abstract]   [Full Text] [Related]  

  • 24. A case suspected for yellow fever vaccine-associated viscerotropic disease in the Netherlands.
    van de Pol EM; Gisolf EH; Richter C
    J Travel Med; 2014; 21(6):421-4. PubMed ID: 24920138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yellow fever - prevention in travellers.
    Neilson AA; Mayer CA
    Aust Fam Physician; 2010 Aug; 39(8):570-3. PubMed ID: 20877751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.
    Jentes ES; Poumerol G; Gershman MD; Hill DR; Lemarchand J; Lewis RF; Staples JE; Tomori O; Wilder-Smith A; Monath TP;
    Lancet Infect Dis; 2011 Aug; 11(8):622-32. PubMed ID: 21798462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Yellow fever: new recommendations].
    Rochat L; Genton B
    Rev Med Suisse; 2014 May; 10(429):1014-9. PubMed ID: 24908746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yellow fever vaccination: some thoughts on how much is enough [Vaccine 23 (2005) 3908-3914].
    Martins RM; Galler R; Freire MS; Camacho LA; de Lourdes S Maia M; Homma A
    Vaccine; 2007 Jan; 25(1):10-1. PubMed ID: 16448728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing standard pretravel health advice--a study in Belgium.
    Van De Winkel K; Van den Daele A; Van Gompel A; Van den Ende J
    J Travel Med; 2007; 14(5):288-96. PubMed ID: 17883459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of adverse events after yellow fever vaccination between elderly and non-elderly travellers: questionnaire survey in Japan over a 1-year period.
    Tanizaki R; Ujiie M; Hori N; Kanagawa S; Kutsuna S; Takeshita N; Hayakawa K; Kato Y; Ohmagari N
    J Travel Med; 2016 Mar; 23(3):. PubMed ID: 27021495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The elderly, the young and the pregnant traveler -- A retrospective data analysis from a large Swiss Travel Center with a special focus on malaria prophylaxis and yellow fever vaccination.
    Jaeger VK; Tschudi N; Rüegg R; Hatz C; Bühler S
    Travel Med Infect Dis; 2015; 13(6):475-84. PubMed ID: 26526774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An inactivated cell-culture vaccine against yellow fever.
    Monath TP; Fowler E; Johnson CT; Balser J; Morin MJ; Sisti M; Trent DW
    N Engl J Med; 2011 Apr; 364(14):1326-33. PubMed ID: 21470010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002.
    Cetron MS; Marfin AA; Julian KG; Gubler DJ; Sharp DJ; Barwick RS; Weld LH; Chen R; Clover RD; Deseda-Tous J; Marchessault V; Offit PA; Monath TP
    MMWR Recomm Rep; 2002 Nov; 51(RR-17):1-11; quiz CE1-4. PubMed ID: 12437192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of yellow fever vaccination practice in England.
    Bryant N; Tucker R; Simons H; Bailey S; Mathewson J; Lea G; Hill DR
    J Travel Med; 2008; 15(5):287-93. PubMed ID: 19006500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unpredictable checks of yellow fever vaccination certificates upon arrival in Tanzania.
    Schönenberger S; Hatz C; Bühler S
    J Travel Med; 2016 May; 23(5):. PubMed ID: 27296582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality improvement in travel medicine: a programme for yellow fever vaccination centres in England, Wales and Northern Ireland.
    Boddington NL; Simons H; Launders N; Hill DR
    Qual Prim Care; 2011; 19(6):391-8. PubMed ID: 22340901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yellow fever and Japanese encephalitis vaccines: indications and complications.
    Marfin AA; Eidex RS; Kozarsky PE; Cetron MS
    Infect Dis Clin North Am; 2005 Mar; 19(1):151-68, ix. PubMed ID: 15701552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
    Barrett AD; Teuwen DE
    Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Informed decision-making and colorectal cancer screening: is it occurring in primary care?
    Ling BS; Trauth JM; Fine MJ; Mor MK; Resnick A; Braddock CH; Bereknyei S; Weissfeld JL; Schoen RE; Ricci EM; Whittle J
    Med Care; 2008 Sep; 46(9 Suppl 1):S23-9. PubMed ID: 18725829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Belgian traveler who acquired yellow fever in the Gambia.
    Colebunders R; Mariage JL; Coche JC; Pirenne B; Kempinaire S; Hantson P; Van Gompel A; Niedrig M; Van Esbroeck M; Bailey R; Drosten C; Schmitz H
    Clin Infect Dis; 2002 Nov; 35(10):e113-6. PubMed ID: 12410495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.